戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and the microbiome in order to predict human disease susceptibility.
2 de lysosomal function, enhancing Parkinson's disease susceptibility.
3 d might serve as a biomarker of exposure and disease susceptibility.
4 rovide new insights into human variation and disease susceptibility.
5 tic architecture both of gene expression and disease susceptibility.
6 l reveal additional variants contributing to disease susceptibility.
7 oms, suggesting their loss may contribute to disease susceptibility.
8 ontributing to chronic obstructive pulmonary disease susceptibility.
9  is more broadly associated with Parkinson's disease susceptibility.
10 ature of our genome in evolution, health and disease susceptibility.
11  gut that alters immune cell homeostasis and disease susceptibility.
12  differences to hepatic metabolism and liver disease susceptibility.
13  transmissible factor dramatically increased disease susceptibility.
14  is a predictor of lifetime neuropsychiatric disease susceptibility.
15 fying sex-specific molecular determinants of disease susceptibility.
16  and age-related physiological variation and disease susceptibility.
17 external influences and may thereby modulate disease susceptibility.
18 s contractility, ventricular remodeling, and disease susceptibility.
19 ach to identifying rare variants involved in disease susceptibility.
20  with additional potential as a biomarker of disease susceptibility.
21 cover rare variants that are associated with disease susceptibility.
22 re common but also have a powerful effect on disease susceptibility.
23 r phenotypic variation of complex traits and disease susceptibility.
24 ophils in inflammatory lesions and influence disease susceptibility.
25 n miRNAs should be explored as the basis for disease susceptibility.
26 an contact has been attributed to infectious disease susceptibility.
27  help to define principles for understanding disease susceptibility.
28 ms underlying human phenotypic variation and disease susceptibility.
29 tate expression levels of HLA associate with disease susceptibility.
30 defense mechanisms that may confer increased disease susceptibility.
31 significance in in vitro cell studies and on disease susceptibility.
32 g to unveil the genomic basis of periodontal disease susceptibility.
33 air to influence life from evolution through disease susceptibility.
34 namic changes in diversity, which can impact disease susceptibility.
35 intestinal microbiota may be associated with disease susceptibility.
36 h age-related changes in lung physiology and disease susceptibility.
37  influence host immune function and modulate disease susceptibility.
38 associations at loci yet to be implicated in disease susceptibility.
39 stic insights into functions associated with disease susceptibility.
40 e as well as functionally mapping regions of disease susceptibility.
41 on in a way that favors bacterial growth and disease susceptibility.
42 enic T cell response and therefore increases disease susceptibility.
43 ivate JA signaling as a mechanism to promote disease susceptibility.
44  = 1.84 x 10(-45)) as relevant positions for disease susceptibility.
45 ion is involved in human trait formation and disease susceptibility.
46 nd unveils genes governing pathogenicity and disease susceptibility.
47 ain links between microbiota composition and disease susceptibility.
48 ing of gut immune responses and inflammatory disease susceptibility.
49 characterize the contribution of genetics to disease susceptibility.
50 ow genetic effects interact to contribute to disease susceptibility.
51 actor in genetic differences in pneumococcal disease susceptibility.
52 iology, the status of the immune system, and disease susceptibility.
53 ctors or mutations might result in increased disease susceptibility.
54  variants in noncoding regions is central to disease susceptibility.
55 ator of Ab production, has a minor effect on disease susceptibility.
56 e a major contributor to genetic disease and disease susceptibility.
57 WAS) have identified many loci implicated in disease susceptibility.
58 host metabolite interactions which may alter disease susceptibility.
59 ction with MAPKKKepsilon and did not promote disease susceptibility.
60 -signaling pathways as contributors to lupus disease susceptibility.
61 t an important role for the IL-12 pathway in disease susceptibility.
62  have a negligible role in common autoimmune disease susceptibility.
63 t PrP is the major determinant of host prion disease susceptibility.
64 its receptor, are associated with autoimmune disease susceptibility.
65 ised in avenacin acylation and have enhanced disease susceptibility.
66 , indicating that these cells contributed to disease susceptibility.
67 c variation has a major impact on infectious disease susceptibility.
68 wing signs of association with meningococcal disease susceptibility.
69 ally informative in studies of evolution and disease susceptibility.
70  abiotic stress-response pathway, to promote disease susceptibility.
71 o telomere homeostasis, with direct links to disease susceptibility.
72 significant role in phenotypic variation and disease susceptibility.
73 is and Acropora palmata to quantify relative disease susceptibility.
74 nomenon that could shape viral evolution and disease susceptibility.
75 T14, the expression of which is required for disease susceptibility.
76  mechanism for sex differences in autoimmune disease susceptibility.
77 ic variation that plays an important role in disease susceptibility.
78 le of germline variation in the IGH locus in disease susceptibility.
79 i, none of which showed any association with disease susceptibility.
80 diate the function of GWAS loci on postnatal disease susceptibility.
81  role for nanoparticle exposure in increased disease susceptibility.
82 e response to microbial exposure in Behcet's disease susceptibility.
83 ed dynamic complexes associated with MTI and disease susceptibility.
84  IDO activity or depletion of Tregs restored disease susceptibility.
85 rdant with known differential cardiovascular disease susceptibilities.
86  insight into its roles in human disease and disease susceptibilities.
87  expression of plant immunity genes enhanced disease susceptibility 1 (EDS1) and isochorismate syntha
88 and functions upstream of the genes enhanced disease susceptibility 1 (EDS1) and N requirement gene 1
89 icylic acid (SA) pathway, including ENHANCED DISEASE SUSCEPTIBILITY 1 (EDS1), EDS1-LIKE 2 (EDL2), EDL
90  phytoalexin-deficient 4 (PAD4) and enhanced disease susceptibility 1 (EDS1), in guard cells that for
91 utoimmunity in cfs1 is dependent on ENHANCED DISEASE SUSCEPTIBILITY 1 (EDS1)-mediated effector-trigge
92 downstream immune signaling complex ENHANCED DISEASE SUSCEPTIBILITY 1 (EDS1)/PHYTOALEXIN DEFICIENT 4
93 ive immune responses and found that enhanced disease susceptibility 4 (eds4) displays alterations in
94                           Moreover, Enhanced Disease Susceptibility 5 (EDS5), a SA transporter requir
95 o the association between MHC haplotypes and disease susceptibility, a deeper understanding of MHC po
96 at impacts metabolic function and determines disease susceptibility across the life-course.
97 epression by PLZF depended on the rs12101261 disease susceptibility allele and was increased by IFNal
98 cular interest, the ATP7B(K832R) Alzheimer's disease susceptibility allele was found, for the first t
99 netic association studies to search for rare disease susceptibility alleles.
100 k for how to deal with identified hereditary disease susceptibilities and how to return the data to p
101 cal trial of 2159 infants with HLA-conferred disease susceptibility and a first-degree relative with
102       In addition to improving prediction of disease susceptibility and broadening our understanding
103 o complex diseases is crucial for predicting disease susceptibility and developing patient-tailored t
104 dy links a germline variant to Ewing sarcoma disease susceptibility and EWSR1-FLI1-mediated gene acti
105 ynpo-deficient mice demonstrated exacerbated disease susceptibility and increased intestinal permeabi
106 anscriptome that ultimately lead to prostate disease susceptibility and may serve as a source of the
107 ient history now influences human infectious disease susceptibility and microbiome homeostasis, and c
108 w social status is an important predictor of disease susceptibility and mortality risk in humans and
109 hese include how host genetic factors affect disease susceptibility and pathogenesis.
110 ay be an important contributor to infectious-disease susceptibility and pathology.
111 s largely independent of the contribution to disease susceptibility and point to a biology of prognos
112 and microbial imbalance or dysbiosis affects disease susceptibility and progression.
113  as 'loss of function' variants, may have on disease susceptibility and quantitative levels of biomar
114  importance of the host genome in infectious disease susceptibility and severity and offer crucial in
115      Particular alleles of HLA contribute to disease susceptibility and severity in many autoimmune c
116 ntifying bacteria that preferentially affect disease susceptibility and severity remains a major chal
117 microbiota signature capable of transmitting disease susceptibility and subject to reprogramming by e
118  implicating CEV as a biomarker of aging and disease susceptibility and suggesting that it might play
119 cial experience is an important predictor of disease susceptibility and survival in humans and other
120 view evidence of the genetic contribution to disease susceptibility and the current state of molecula
121 ecular mechanisms by which these loci confer disease susceptibility and the extent to which shared lo
122 ding of the contribution of host genetics to disease susceptibility and to drug treatment.
123 tionary forces that have shaped inflammatory-disease susceptibility and to elucidate functional pathw
124 nisms underlying PF4/heparin immunogenicity, disease susceptibility, and clinical manifestations of d
125  repertoires has been associated with aging, disease susceptibility, and differential response to inf
126 ice demonstrate a role for Il2 in autoimmune disease susceptibility, and for decades the proximal Il2
127 a (ALL) biology, including associations with disease susceptibility, and increased risk of central ne
128 ithin individuals may serve as a read-out of disease susceptibility, and is thus potentially a valuab
129 or exploring relationships among global DRC, disease susceptibility, and optimal treatment.
130  understanding how genetic diversity impacts disease susceptibility, and raises important concepts ab
131 iRNAs are emerging as putative biomarkers of disease, susceptibility, and perhaps dietary exposure.
132            Sex differences in physiology and disease susceptibility are commonly attributed to develo
133    We demonstrate that loci for inflammatory-disease susceptibility are enriched for genomic signatur
134 ausative relationships between infection and disease susceptibility are lacking.
135  mechanisms by which these variants increase disease susceptibility are largely unknown.
136 ng environmentally-induced transgenerational disease susceptibility are poorly understood.
137            We explore emerging evidence that disease susceptibility arises from early changes in the
138  Indels can be deleterious and contribute to disease susceptibility as recent genome sequencing proje
139 -null mice revealed a remarkable increase in disease susceptibility associated with increased intesti
140 atures, we have developed a method, SuSPect (Disease-Susceptibility-based SAV Phenotype Prediction),
141  and is often associated with differences in disease susceptibility between individuals.
142 few studies have directly compared metabolic disease susceptibility between NNT-deficient 6J mice and
143  underpinnings of cognition and neurological disease susceptibility between species.
144 ardiovascular disorders, obesity, infectious disease susceptibility, blood disorders, neurosensory di
145  suppress plant immune responses and promote disease susceptibility but has also facilitated the disc
146 ing 9 (TNRC9; TOX3) has been associated with disease susceptibility but its function is undetermined.
147 le-specific methylation (hap-ASM) can impact disease susceptibility, but maps of this phenomenon usin
148 variants in these regulatory elements modify disease susceptibility by regulating the expression of g
149                                              Disease susceptibility can arise as a consequence of ada
150 nthesis gene expression and display enhanced disease susceptibility compared to wild-type plants.
151  in the miRNA binding sites, suggesting that disease susceptibilities could be attributed to ceRNA re
152  effect of multiple variants in a pathway on disease susceptibility could be large.
153 er on microbiome composition, and subsequent disease susceptibility, depended on the host genotype.
154 ce of Africa to studies of human origins and disease susceptibility, detailed characterization of Afr
155 ng mechanisms and patterns of variability in disease susceptibility, disease evolution, and drug resp
156 interaction databases to identify windows of disease susceptibility during development and the time p
157 r current understanding of RMS epidemiology, disease susceptibility factors, disease mechanisms and e
158 ntially be used to facilitate predictions of disease susceptibility for more precise and timely appli
159                                              Disease susceptibility for type 1 diabetes is strongly a
160 n APOE varepsilon3/4 and another Alzheimer's disease susceptibility gene and demonstrate in proof of
161 species of Xanthomonas exploit a single host disease susceptibility gene by altering the expression o
162             Clec16a has been identified as a disease susceptibility gene for type 1 diabetes, multipl
163 cing a shocking incident, but the underlying disease susceptibility gene networks remain poorly under
164 ction protects mice deficient in the Crohn's disease susceptibility gene Nod2 from intestinal abnorma
165 olog of the SWEET sugar transporter and rice disease susceptibility gene.
166 cell survival, our data implicate TWEAK as a disease-susceptibility gene for a humoral immunodeficien
167 he sucrose transporter gene OsSWEET13 as the disease-susceptibility gene for PthXo2 and the existence
168 ssive resistance gene xa13, an allele of the disease-susceptibility gene Os8N3 (also named Xa13 or Os
169 f host-microbe intersection, notably several disease susceptibility genes and sterol metabolism pathw
170 ent studies identified over half of the HSCR disease susceptibility genes as targets for the sex-dete
171 y between drug targets, somatic mutants, and disease susceptibility genes by utilizing directionality
172   MED18 interacts with YIN YANG1 to suppress disease susceptibility genes glutaredoxins GRX480, GRXS1
173                      Finally, cardiovascular disease susceptibility genes identified using public gen
174 ctors (TALEs) that activate transcription of disease susceptibility genes in the host, inducing a sta
175 uggest that autophagy and inflammatory bowel disease susceptibility genes regulate inflammatory respo
176 s have been successfully applied to identify disease susceptibility genes with genetic markers such a
177  SLC17A5, and ASAH1 as candidate Parkinson's disease susceptibility genes.
178  of Ret and loss of Sema3d, two Hirschsprung disease susceptibility genes.
179 ling is a helpful approach in the search for disease susceptibility genes.
180 icated biological mechanisms and for mapping disease susceptibility genes.
181 xpression profile of specific transcripts of disease-susceptibility genes is for the first time descr
182 end to lie upstream of somatic mutations and disease susceptibility germline variants.
183   The risk factors are largely undefined but disease susceptibility has been associated with human le
184                        Asthma and autoimmune disease susceptibility has been strongly linked to genet
185                 While heritable variation in disease susceptibility has been targeted in livestock br
186 er variation's contribution to complex human disease susceptibility have been performed.
187 ators (e.g., trimethylamine N-oxide) of host disease susceptibility have created novel potential ther
188 the sex- and strain-dependent differences in disease susceptibility have not been described.
189 ssociated with chronic obstructive pulmonary disease susceptibility (HHIP, IREB2/CHRNA3, CYP2A6/ADCK,
190 f elevated IL18 levels on inflammatory bowel disease susceptibility (IBD) in 12,882 cases and 21,770
191 idate genes were tested for association with disease susceptibility in 2,101 cases and 4,202 controls
192  the different HLA-DR15 haplotype alleles on disease susceptibility in a new "humanized" model of MS
193 SPC Cre(+)) revealed a selective increase in disease susceptibility in Adora2b(loxP/loxP) SPC Cre(+)
194 g genetic variation influencing inflammatory-disease susceptibility in humans.
195 ed to determine how these alterations impact disease susceptibility in L. pipiens.
196 nsights on the mechanism of disproportionate disease susceptibility in men and identify antiandrogeni
197                                              Disease susceptibility in mice and microbial colonizatio
198 stimulation with this moiety alone overrides disease susceptibility in mice depleted of commensal bac
199 pe hypersensitivity responses and autoimmune disease susceptibility in mice.
200  HSV-1 infection and as a novel cause of HSE disease susceptibility in mice.
201 enter stage in the study of pathogenesis and disease susceptibility in plants and humans.
202  the potential of one developmental gene for disease susceptibility in rice/Xoo interactions.
203 environmental stressors is known to increase disease susceptibility in unexposed descendants in the a
204 r-latitude hosts, we hypothesised that their disease susceptibility increases under 'thermal mismatch
205 ciation of autophagy with inflammatory bowel disease susceptibility, increasing evidence indicates th
206  microbiome assembly history can affect host disease susceptibility independent of microbiome composi
207 ty of effector-associated gene induction and disease susceptibility is attributable to a single nucle
208 Direct-to-consumer (DTC) genetic testing for disease susceptibility is largely dominated by 2 extreme
209 nical relevance of microbiome alterations on disease susceptibility is still in its infancy, but the
210 auterine conditions that influence offspring disease susceptibility is warranted to inform targeted e
211 G) allele, despite not being associated with disease susceptibility, is associated with a milder cour
212 models to mapping the genetic basis of human disease susceptibility, knowing whether a single disrupt
213                 We identified 111 additional disease-susceptibility locations, 93 of which are cosmop
214  new associations between inflammatory bowel disease susceptibility loci and gene expression.
215  were mapped and examined for enrichment for disease susceptibility loci annotated in the genome-wide
216 rs interested in mapping common and uncommon disease susceptibility loci by focusing on output linkin
217 attempting to functionally interpret complex-disease susceptibility loci by GWAS and eQTL integration
218                                         Many disease susceptibility loci colocalize with DNA regulato
219 erves as a good alternative method to detect disease susceptibility loci for clinic genomic data.
220  additional candidate-gene annotation for 37 disease susceptibility loci for human atherosclerotic di
221 nts, such as discoveries of large numbers of disease susceptibility loci from genome-wide association
222 application to prioritize candidate genes in disease susceptibility loci identified by GWAS.
223 Conversely, the aggregated effect of all 170 disease susceptibility loci was not associated with dise
224 tes to understanding the biology of specific disease susceptibility loci.
225 motifs, and annotated several cardiovascular disease susceptibility loci.
226       Despite the large number of identified disease-susceptibility loci, it is not known which loci
227 quantitative phenotypes to identify putative disease-susceptibility loci.
228 pendent selection plausibly acted on a human disease susceptibility locus, a form of balancing select
229 unctional dissection of the CD33 Alzheimer's disease susceptibility locus, we found that the rs386544
230  variants and may help to predict or explain disease susceptibility more accurately and comprehensive
231  an association between SMAD5 levels and PAH disease susceptibility (odds ratio, 0.317; 95% confidenc
232 s are predicted to play an important role in disease susceptibility of common diseases.
233                          However, the lesser disease susceptibility of Hispanic populations with comp
234 tralization of CXCL10 reversed the increased disease susceptibility of Il22bp-deficient mice.
235                                              Disease susceptibility of influenza is determined by hos
236 nduced inflammation contributes to metabolic disease susceptibility of the offspring via alterations
237 ow pH, and correlates with the difference in disease susceptibility of the two species, as expected f
238 ding how human genetics influence infectious disease susceptibility offers the opportunity for new in
239                         SNPs associated with disease susceptibility often reside in enhancer clusters
240 nal polymorphisms in MIF are associated with disease susceptibility or clinical severity.
241 vered that provide insights into pathways of disease susceptibility or neurotoxicity.
242  as disease-specific biomarkers or influence disease susceptibility or progression.
243  activate the cognate host genes, leading to disease susceptibility or resistance dependent on the ge
244 entify immunological mechanisms that control disease susceptibility or resistance to provide novel ta
245 autophagy responses could be associated with disease susceptibility or severity.
246 valence, indicating significant variation in disease susceptibility or tolerance.
247 cal Transcriptome (SWOT) Clocks illustrating disease susceptibility over developmental time.
248 rstanding how these mechanisms contribute to disease susceptibility, particularly in infants with dev
249 ads to biallelic expression which may affect disease susceptibility possibly reflected in high levels
250 ical for signaling downstream of the Crohn's disease susceptibility protein nucleotide-binding oligom
251 terodimer and its potential association with disease susceptibility, provides a rationale for a poten
252 lowing inoculation and increased periodontal disease susceptibility, reflected by higher TNF levels a
253 -wide association studies indicate that many disease susceptibility regions reside in non-protein-cod
254 n, while BATF and ESRRA overlap other immune disease susceptibility regions, validating our approach
255 acteristics of ageing that lead to increased disease susceptibility remain inadequately understood.
256 st of the genetic factors that contribute to disease susceptibility remain unknown.
257 lecular and biological mechanisms explaining disease susceptibility remains challenging.
258 ved in gene regulation whose contribution to disease susceptibility remains to be fully understood.
259 which specific fatty acids affect infectious disease susceptibility remains unclear.
260 hylation in these AD loci contributes to the disease susceptibility remains unknown.
261                                 Mutations in disease susceptibility (S) genes, here referred to as re
262 y HLA-DRB1 haplotypes was correlated between disease susceptibility, severity, and mortality, but inv
263 e cell receptors and proteins that determine disease susceptibility shed light on how different arms
264 r's patches and the spleen was impaired, and disease susceptibility significantly reduced.
265 umour (TGCT), revealing a polygenic model of disease susceptibility strongly influenced by common var
266 ests that fungal proteins involved in either disease susceptibility such as ToxB or resistance such a
267 enome-wide association studies contribute to disease susceptibility, systems genetics is likely to be
268 ngly, we revealed appreciable differences in disease susceptibility, temporal patterns, network struc
269 roles of innate immunity, sex differences in disease susceptibility, the necessity for adjuvants in e
270 exposure may therefore shed light on complex disease susceptibility.The goal was to analyze the progr
271 bial identities and how this might determine disease susceptibility, therapeutic responses and recove
272  numerous genome-wide association studies of disease susceptibility, there is increasing interest in
273 loci, these OA loci are thought to influence disease susceptibility through the regulation of gene ex
274  and double-mutant plants exhibited enhanced disease susceptibility to cucumber mosaic virus when the
275 d VINR-knockout adult flies exhibit enhanced disease susceptibility to DCV and bacteria.
276 ata are consistent with a polygenic model of disease susceptibility to MGUS.
277 methasone-inducible HopQ1 exhibited enhanced disease susceptibility to virulent Pto DC3000, the Pto D
278 expression for the state of PthXo2-dependent disease susceptibility to X. oryzae pv. oryzae.
279 to a more diverse ethnic group for gallstone disease, susceptibility to biliary cancer, and show vari
280 6D phosphomimetic mutants exhibited enhanced disease susceptibility upon surface inoculation with P.
281      We applied this method to meningococcal disease susceptibility, using the DNA binding pattern of
282 easures: Identification of a novel, germline disease susceptibility variant in a previously uncharact
283                 Objective: To identify novel disease susceptibility variants in a familial syndrome o
284 rrett esophagus family to identify candidate disease susceptibility variants.
285 d to identify the cell-autonomous effects of disease susceptibility variants.
286                         So far, three common disease-susceptibility variants at the RET, SEMA3 and NR
287               Recent studies have shown that disease-susceptibility variants frequently lie in cell-t
288                Our data show that oral prion disease susceptibility was dramatically reduced in mice
289  dendritic cells was impaired and oral prion disease susceptibility was reduced.
290 the HLA-DRB1 locus, which is associated with disease susceptibility, was also associated with radiolo
291        To gain insight into the evolution of disease susceptibility, we characterized gene expression
292 ent is a critical epoch for neuropsychiatric disease susceptibility, we characterized the genetic con
293  Because Fcgamma receptors are implicated in disease susceptibility, we crossed HLA transgenic mice o
294     However, they demonstrate alterations in disease susceptibilities when exposed to a variety of va
295 utations of Nppa, Plod1, and Mthfr increased disease susceptibility, whereas Agtrap and Clcn6 mutatio
296 ironmental and genetic factors contribute to disease susceptibility, whereas the immunopathogenesis o
297  their reprogramming into Th2-like cells and disease susceptibility, whereas Treg-cell-lineage-specif
298 D have identified common variants underlying disease susceptibility, while gene expression microarray
299 uggests that at least 400 variants influence disease susceptibility, with potentially many thousands.
300 crobiome co-evolution drives homeostasis and disease susceptibility, yet regulatory principles govern

 
Page Top